Argenx

Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), Argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.